Sarepta Therapeutics’ report of a second fatality this year in a patient dosed with its Duchenne muscular dystrophy gene therapy raised the prospect it might have to pull the product from the market.

Turquoise Health raised $40 million in a Series C round to expand beyond price transparency into managing healthcare ...

Stryker was hit by a cyberattack this week that knocked out its internal systems worldwide and caused delays to order ...

Employer groups praised a bill aimed at boosting healthcare competition and lowering costs by banning anticompetitive insurer-provider contracts.

Universal Health Services plans to acquire Talkspace for $835 million to create a national behavioral health platform that ...

Jason Prestinario, CEO of Particle Health, cuts through the noise of interoperability challenges to highlight where real progress is finally happening in data exchange. Jeff Comeau, Strategic Advisor ...

Over the past month, two large provider organizations have announced partnerships with Reimagine Care, a Nashville-based startup focused on providing support to cancer patients who are in active ...

GuardDog Telehealth admitted it misrepresented its services to access patients’ health information, marking the first major concession in Epic’s lawsuit against Health Gorilla and other defendants ...

AbbVie has inflammatory bowel disease covered with blockbuster drugs now on the market and additional drug candidates in clinical development. The pharmaceutical giant is diversifying its IBD ...

To combat rising healthcare costs, employers may be looking to reduce healthcare benefits in 2026, according to a new survey from consulting firm Mercer. The survey, released Wednesday, revealed that ...

With roughly two in five U.S. adults affected by obesity, GLP-1 drugs have emerged as a promising solution — but their steep price remains a significant hurdle. For instance, GLP-1 drugs have a list ...